WA-KYMETA
Kymeta (www.kymetacorp.com ), the communications company making mobile global, and Kepler Communications (www.kepler.space ) announced today the successful demonstration of the Kymeta u8 Terminal with LEO satellite acquisition , tracking and throughput measurements, during extreme cold weather temperatures. The collaboration with Kepler supports Kymeta’s goal to develop solutions that are future proof with a clear LEO upgrade path and compatible with growing mega constellations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210323005226/en/
In 2020, Kepler was selected for an extended u8 beta trial to capture the extended Northern winter in Inuvik, Canada. Frequent revisit times from the Kepler LEO satellites combined with the local environment of unprotected cold weather, snow, and ice provided a unique testing opportunity for the latest Kymeta technology. Results have demonstrated a significant increase in performance with lower latency, enhanced look angles and speeds that are approaching 10X faster than earlier products with higher throughput and total data passed.
The u8 system is designed to work down to -40o C. During testing, Kymeta and Kepler were able to update software facilitating the testing of new algorithms in real time. Updates included capabilities of on-board FPGA-based tracking receivers, which allowed for usage of channels more than 2 times larger than previous demonstrations.
Testing results exceeded expectations during these cold weather trials with average uplink and downlink speeds of 100 Mbps, providing the ability to transfer more than two gigabytes of data with each pass. Initial testing was completed using linear polarization on the u8 – in a future software upgrade the addition of circular polarization support will lead to additional increases in data transfer speeds.
“Kepler has been a great trial partner because they are agile and able to make adjustments for optimized performance at the same time we are adjusting the u8 terminal,” said David Harrower, Senior Vice President of Global Sales at Kymeta. “Many of our customers are interested in compatibility with LEO satellite services, and this testing helps ensure the longevity of the u8 and Kymeta Connect as well as offer a solution that takes advantage of the increased utility of LEO satellites.”
"The performance of the Kymeta u8 with Kepler's Global Data Service has exceeded our expectations," said Wen Cheng Chong, Kepler's CTO and Co-Founder. "Our recent testing and development efforts demonstrated not only the ability to move many more gigabytes of data than expected with each pass, but also the u8's ability to operate in polar environments, where many of Kepler's early adopters operate. With Kepler's recently increased capacity the u8 can serve customers globally, pole-to-pole and all points in between."
In January, Kepler launched 8 new satellites via SpaceX’s first dedicated SmallSat Rideshare Program. On March 22nd , Kepler launched an additional two satellites via the Soyuz-2, expanding its active constellation to 15 satellites in total. An additional launch is planned for June. Kymeta believes the collaboration with Kepler and further testing is instrumental to providing reliable connectivity and superior benefits to customers.
Kymeta next-generation solutions are built for mobility and designed specifically for the needs of global defense agencies, government, public safety, and commercial customers. Through the launch of the u8 and Kymeta Connect, the company has meaningfully increased antenna throughput and reduced the total cost of ownership. Its products offer a breakthrough in performance, ease of use, and hybrid satellite-cellular connectivity services.
About Kymeta
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
About Kepler Communications Inc.
Kepler is a satellite telecommunications provider based in Canada, backed by Costanoa Ventures, IA Ventures and other leading investors. Kepler’s mission is to connect people and things Everywhere, on earth and beyond. To this end, Kepler will build an in-space telecommunications network through an incremental deployment of products and technologies. The first to launch and operate a Ku-band satellite service in Low Earth Orbit, Kepler has expanded its capabilities with the successful commissioning of a cubesat production facility at their Toronto headquarters, from which the GEN 1 satellites are being delivered.
For more information, visit www.kepler.space and @KeplerComms.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210323005226/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands12.1.2026 13:30:00 CET | Press release
Cellares’ new IDMO Smart Factory in Leiden, Netherlands, expands commercial-scale manufacturing capacity for European cell therapy patient populations through a standardized, automated, and highly scalable facility model Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced it has secured a site and signed a long-term lease for a new IDMO Smart Factory at Leiden Bio Science Park (LBSP) with Dura Vermeer Commercieel Vastgoed. The facility will serve as Cellares’ European headquarters and expand the company’s global manufacturing network with dedicated regional capacity. Cell therapy manufacturing is patient-specific and time-sensitive, making regional production capacity increasingly important as programs advance from clinical development toward commercial supply. The new Netherlands hub is designed to provide European drug developers with access to automated manufacturing infrastructure, while maintaining alignment to a common production stan
France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas12.1.2026 13:30:00 CET | Press release
Updated national AAC protocol supports hospital-based, fully-reimbursed compassionate access across three solid tumor settings Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that France’s National Agency for Medicines and Health Products Safety (ANSM) has approved an updated national treatment protocol for botensilimab (BOT) plus balstilimab (BAL) under France’s Autorisation d’Accès Compassionnel (AAC) framework. The updated protocol expands France’s previously granted AAC authorization for BOT+BAL in patients with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases to eligible patients with certain ovarian cancers and soft-tissue sarcomas—diseases with substantial unmet medical need after standard options have been exhausted. The revised protocol is designed to broaden the eligibility criteria, allowing more patients with advanced solid tumors to have early access to BOT+BAL under reimbursed compassionate
Lilac and Traxys Announce Binding 10-Year Offtake Agreement for Great Salt Lake Lithium Production12.1.2026 13:00:00 CET | Press release
Definitive agreement secures 100% of Phase 1 production, advancing project toward final investment decision Lilac Solutions, a leading provider of direct lithium extraction technology, and Traxys North America, a leading global physical trader and merchant in metals and natural resources, today announced a binding 10-year offtake agreement for lithium carbonate produced at Lilac's Great Salt Lake facility in Utah. The agreement represents a major milestone in advancing the project toward construction and establishes a clear commercial pathway for one of the nearest-term domestic lithium projects in the United States. Under the terms of the definitive agreement, Traxys will purchase 50,000 tonnes of lithium carbonate over a 10-year period, representing 100% of the planned Phase 1 production capacity. The agreement is take-or-pay, with agreed pricing mechanisms linked to market indices. The Great Salt Lake Phase 1 facility is designed to produce 5,000 tonnes per annum of battery-grade li
Enginzyme and AGC Create Scalable Process for Key mRNA Ingredient12.1.2026 06:00:00 CET | Press release
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP). The rapid growth of mRNA-based vaccines and therapeutics has driven significant demand for modified nucleotides like m¹ΨTP, which enhances mRNA stability and expression, while reducing immunogenicity. Enginzyme is a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology. AGC Inc. is a leading global player in fields spanning from architectural glass to chemicals and life science. AGC Inc. provides services in a wide range of life science fields, from synthetic pharmaceuticals and agrochemicals, to biopharmaceuticals and leading-edge cell and gene therapies, as well as messenger RNAs. The presentation in November detailed the latest collaboration between the companies, with a focus on the biomanufacturing of nucleotides for mRNA therapy,
Ant International Partners with Google’s Universal Commerce Protocol to Expand AI Capabilities12.1.2026 02:15:00 CET | Press release
Ant International, a leading global payment, digitisation, and financial technology provider, is collaborating on the launch of Google’s Universal Commerce Protocol (UCP), a new open standard for agentic commerce that works across the entire shopping journey — from discovery and buying to post-purchase support. UCP establishes a common language for agents and systems to operate together across consumer surfaces, businesses, and payment providers to enable commerce. So instead of requiring unique connections for every individual agent, UCP enables all agents to interact easily. UCP is built to work across verticals and is compatible with existing industry protocols like Agent2Agent (A2A), Agent Payments Protocol (AP2), and Model Context Protocol (MCP). “For agentic commerce to scale, it’s critical for the industry to align on a common set of standards. We are proud to have Ant International endorse the Universal Commerce Protocol as the foundation for that future,” said Ashish Gupta, VP
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom